1. Home
  2. TKC vs KRYS Comparison

TKC vs KRYS Comparison

Compare TKC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKC
  • KRYS
  • Stock Information
  • Founded
  • TKC 1993
  • KRYS 2015
  • Country
  • TKC Turkey
  • KRYS United States
  • Employees
  • TKC N/A
  • KRYS N/A
  • Industry
  • TKC Telecommunications Equipment
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TKC Telecommunications
  • KRYS Health Care
  • Exchange
  • TKC Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • TKC 5.9B
  • KRYS 4.8B
  • IPO Year
  • TKC 2000
  • KRYS 2017
  • Fundamental
  • Price
  • TKC $6.45
  • KRYS $164.83
  • Analyst Decision
  • TKC
  • KRYS Strong Buy
  • Analyst Count
  • TKC 0
  • KRYS 7
  • Target Price
  • TKC N/A
  • KRYS $206.67
  • AVG Volume (30 Days)
  • TKC 345.3K
  • KRYS 309.7K
  • Earning Date
  • TKC 11-07-2024
  • KRYS 11-04-2024
  • Dividend Yield
  • TKC 3.40%
  • KRYS N/A
  • EPS Growth
  • TKC N/A
  • KRYS N/A
  • EPS
  • TKC 0.52
  • KRYS 1.77
  • Revenue
  • TKC $3,316,791,168.00
  • KRYS $241,519,000.00
  • Revenue This Year
  • TKC $57.99
  • KRYS $485.65
  • Revenue Next Year
  • TKC $32.62
  • KRYS $58.64
  • P/E Ratio
  • TKC $4.99
  • KRYS $92.96
  • Revenue Growth
  • TKC N/A
  • KRYS 2722.80
  • 52 Week Low
  • TKC $4.61
  • KRYS $107.50
  • 52 Week High
  • TKC $8.47
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • TKC 40.00
  • KRYS 40.33
  • Support Level
  • TKC $6.59
  • KRYS $155.16
  • Resistance Level
  • TKC $6.85
  • KRYS $176.59
  • Average True Range (ATR)
  • TKC 0.11
  • KRYS 9.47
  • MACD
  • TKC -0.03
  • KRYS -2.78
  • Stochastic Oscillator
  • TKC 13.04
  • KRYS 23.79

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, Netherlands, and Ukraine. It has three main reportable segments, Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment that derives the majority of revenue comprises mainly telecommunication and technology services activities.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: